| . |
Guedj, Ilan's
Scholarly Papers
Click on the title of any column to sort the table by that
column. |
|
|
| |
|
|
Aggregate Statistics |
|
Total
Downloads
5,160 |
Total
Citations
85 |
|
|
|
|
|
1.
|
|
|
Huang, Jennifer C.
University of Texas at Austin - Department of Finance Guedj, Ilan
Analysis Research Planning Corporation (ARPC)
|
| Posted: |
|
24 Mar 08
|
|
Last Revised:
|
|
17 Nov 09
|
|
1,904
(3,107)
|
9
|
|
| |
|
| |
ETF, Index Mutual Fund, Transaction Costs
|
|
|
2.
|
|
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC) Papastaikoudi, Jannette
Integrated Finance LTD
|
|
1,036
(8,887)
|
28
|
|
| |
|
| |
Mutual Funds, Mutual Fund Families, Performance Persistence, Organizational Structure
|
|
|
3.
|
|
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC) Barnea, Amir
HEC Montreal
|
| Posted: |
|
01 Mar 07
|
|
Last Revised:
|
|
18 Mar 09
|
|
967
(9,886)
|
19
|
|
| |
|
| |
Executive compensation, Networks, Directors, Corporate Governance
|
|
|
4.
|
|
Ownership vs. Contract: How Vertical Integration Affects Investment Decisions in Pharmaceutical R&D
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC)
|
|
Posted:
|
|
28 Feb 05
|
|
Last Revised:
|
|
14 Jul 08
|
|
486
(26,756)
|
5
|
|
|
|
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC)
|
| Posted: |
|
07 Mar 05
|
|
Last Revised:
|
|
14 Jul 08
|
|
337
|
5
|
|
| |
|
| |
Vertical Integration, Investment Decisions, Internal Capital Markets, Pharmaceutical Industry
|
|
|
|
|
|
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC)
|
|
149
|
5
|
|
| |
|
| |
Vertical Integration, Investment Decisions, Internal Capital Markets, Pharmaceutical Industry
|
|
|
|
|
|
5.
|
|
Internal Capital Allocation and Firm Performance
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC) Huang, Jennifer C.
University of Texas at Austin - Department of Finance Sulaeman, Johan
Southern Methodist University (SMU) - Edwin L. Cox School of Business
|
|
Posted:
|
|
15 Jan 09
|
|
Last Revised:
|
|
18 Mar 10
|
|
382
(36,440)
|
|
|
|
|
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC) Huang, Jennifer C.
University of Texas at Austin - Department of Finance Sulaeman, Johan
Southern Methodist University (SMU) - Edwin L. Cox School of Business
|
| Posted: |
|
22 Mar 09
|
|
Last Revised:
|
|
18 Mar 10
|
|
256
|
|
|
| |
|
| |
internal capital allocation, firm performance, stock return
|
|
|
|
|
|
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC) Huang, Jennifer C.
University of Texas at Austin - Department of Finance Sulaeman, Johan
Southern Methodist University (SMU) - Edwin L. Cox School of Business
|
| Posted: |
|
15 Jan 09
|
|
Last Revised:
|
|
17 Jan 10
|
|
126
|
|
|
| |
|
| |
internal capital allocation, firm performance, stock return
|
|
|
|
|
|
6.
|
|
Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms
|
Show Abstracts |
Hide Abstracts |
Versions (2)
|
hide multiple versions |
Export Bibliographic Info |
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC) Scharfstein, David S.
Harvard Business School - Finance Unit
|
|
Posted:
|
|
19 Nov 04
|
|
Last Revised:
|
|
14 Dec 04
|
|
336
(42,647)
|
24
|
|
|
|
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC) Scharfstein, David S.
Harvard Business School - Finance Unit
|
|
62
|
24
|
|
| |
|
| |
|
|
|
|
|
|
|
Guedj, Ilan
Analysis Research Planning Corporation (ARPC) Scharfstein, David S.
Harvard Business School - Finance Unit
|
|
274
|
24
|
|
| |
|
| |
Internal capital markets, resource allocation, drug development, financial resources
|
|
|
|
|
|
7.
|
|
|
Deng, Geng
Securities Litigation and Consulting Group Guedj, Ilan
Analysis Research Planning Corporation (ARPC) McCann, Craig J.
Securities Litigation and Consulting Group Mallett, Joshua
Securities and Exchange Commission (SEC)
|
| Posted: |
|
08 Jan 12
|
|
Last Revised:
|
|
26 Dec 12
|
|
49
(204,316)
|
|
|
| |
|
| |
Structured Products, Barrier Option, Absolute Return Barrier Notes, Principal Protected
|
|
